Dr Ibolya Kepiro
Working in London’s National Physical Laboratory, Dr Ibolya Kepiro is a leading expert in the lesser-known but quietly important science of biometrology – measurement in the life sciences. Her pioneering work has led to novel standards that underpin life-saving research in diagnostics vaccinology, virology and drug development, earning her multiple prestigious awards.
Dr Ibolya Kepiro
Working in London’s National Physical Laboratory, Dr Ibolya Kepiro is a leading expert in the lesser-known but quietly important science of biometrology – measurement in the life sciences. Her pioneering work has led to novel standards that underpin life-saving research in diagnostics, vaccinology, virology and drug development, earning her multiple prestigious awards.
I can quantify the diameter of a virus, the spacing between DNA strands, the thickness of a membrane, or the size of a drug-delivery particle with extraordinary precision.
Dr Ibolya Kepiro studies the smallest building blocks of life at a magnification of a million times using electron microscopy. “But it’s not only about seeing them,” she explains, “it’s about measuring them. This helps us understand how healthy cells function and how they malfunction in disease.”
Ibolya is a leading expert in biometrology, or biological measurement. Highly respected in her field, her work has wide-ranging impact, including the development of reference materials and methods, from initial concepts through to inter-laboratory comparisons and formalised international standards.
“When I was a child, I wanted to be a medical doctor,” she explains. “Over time, I realised that through research, I could shape medicine more broadly by developing the tools, technologies and measurement approaches that make earlier diagnosis and better treatment possible. That possibility for wider impact is what drew me fully into science.”
Shaping scientific innovation
Initially from Hungary, Ibolya knew she wanted to travel. She studied medicine with a focus on experimental research and diagnostics in ophthalmology at the University of Szeged, including a master's in Biomedical Physics, before heading to London for her PhD at Imperial. “It was such an incredible opportunity,” she says.
Ibolya with her parents on a family trip around Europe. Ibolya lost her father last year. "He would have been so proud of me winning this award," she says.
Ibolya with her parents on a family trip around Europe. Ibolya lost her father last year. "He would have been so proud of me winning this award," she says.
“My interest at that time was in developing an instrument for high resolution imaging of human retinas in vivo. It was not really possible to visualise photoreceptors, and only world-leading academic institutions like Imperial offered the opportunity to explore this field.”
And how did Imperial help develop her ambitions? “My time at Imperial was truly formative. I completed my PhD in 2013, developing a novel imaging instrument and validating it for early diagnosis of retinal diseases at the cellular level. It was an incredibly challenging and rewarding project that required deep domain knowledge and close collaboration with clinicians. That experience really shaped the way I approach scientific and technological innovation today.”
Ibolya in the Blackett Laboratory in the Department of Physics in 2009
Ibolya in the Blackett Laboratory in the Department of Physics in 2009
But it wasn’t just the opportunity to innovate and push boundaries that Ibolya enjoyed. People and culture were just as important.
Being immersed in an environment where excellence is the norm pushed me to maintain high standards, think rigorously, and stay curious.
“I also built lifelong friendships and professional relationships that continue to be both personally meaningful and professionally valuable,” she says. And she thrived in London. “Living on the South Kensington campus added another dimension. Being steps away from the Natural History Museum, the Science Museum and the Royal Albert Hall, and taking in lunchtime concerts in the Imperial Chapel, made the whole experience culturally rich as well as academically transformative.”
Ibolya with Imperial friends and colleagues at her graduation
Ibolya with Imperial friends at her graduation
Imperial helped to prepare her for a career in science in many different ways. “Firstly, the technical training has been directly applicable,” she says. “The physics, imaging science, and problem-solving skills I gained are still central to my work in diagnostics innovation. Secondly, the PhD taught me how to manage complex projects under pressure and how to collaborate across disciplines, especially with engineers, clinicians, and industry partners. Those capabilities have been essential in driving forward technologies that have real impact.”
Having an Imperial background has opened doors. It carries a credibility that supports new collaborations and leadership opportunities. Overall, Imperial didn’t just give me a PhD — it gave me a habit of rigorous thinking and a comfort with complexity.
“These foundations have been indispensable in my career in diagnostics innovation, where clarity of measurement and methodological integrity are essential. Imperial provided not only technical mastery but a mindset that continues to shape my scientific judgement.”
She describes the Alumni Award as “a profound honour,” crediting her parents with her success. “I owe so much to my family, especially my parents, who encouraged my curiosity, trusted my ambitions and supported my early fascination with science. Their belief in me made this path possible. And, of course, this recognition reflects the many mentors, colleagues and collaborators who have walked alongside me. I am truly grateful.”
Ibolya with her parents on a family trip around Europe. Ibolya lost her father last year. "He would have been so proud of me winning this award," she says.
Ibolya with her parents on a family trip around Europe. Ibolya lost her father last year. "He would have been so proud of me winning this award," she says.
Developing effective standards for diagnosis
Following her time at Imperial, Ibolya took up a postdoctoral research fellowship in Genoa, Italy, before returning to the UK to join the National Physics Laboratory. Her work here, in the field of biometrology, is vital.
We develop standards and methods so that when we say a virus is a certain size, or a therapy behaves in a certain way, everyone can trust that number.
“It’s about ensuring that these incredibly small measurements are accurate, comparable and replicable across different laboratories, hospitals and countries. This is essential for new diagnostics, vaccines and treatments to be safe, effective and approved for clinical use.”
One of her proudest achievements is a breakthrough that changed how scientists use electron microscopes. By developing a “nano-ruler”, she helped make it possible to take accurate, traceable measurements at scales once thought too small to standardise. The work marked a world first, transforming electron microscopy from a largely visual science into one that supports reliable, comparable measurements. The implications for biomedical research are far-reaching: it is relevant for the validation of plaque formation in neurodegenerative diseases like Alzheimer’s or Parkinson, and it has been adopted clinically in the diagnosis of kidney and brain biopsies.
Ibolya at the Asia Pacific Metrology Programme annual conference with international delegates
Ibolya at the Asia Pacific Metrology Programme annual conference with international delegates
Biometrology is an unfamiliar branch of science to many, but Ibolya is committed to ensuring accurate standards are developed, maintained and upheld. She’s received numerous awards and accolades for doing so, including NPL’s prestigious Rayleigh Award.
Changing our approach to disease
In the long term, Ibolya would like to set up her own laboratory, bringing together a multidisciplinary team that works at the interface of biology, physics and clinical science. “My aim is to create a space where advanced measurement techniques, nanotechnology and innovative materials are developed not just as scientific achievements, but as tools that genuinely transform healthcare.”
Ultimately, I want to contribute to a shift in how we approach disease, moving from reactive treatment to truly predictive and preventive healthcare.
“Building a laboratory that can drive that kind of transformation, in partnership with clinicians, hospitals and international collaborators, is the direction I see for the next decade.”
Leading the future
In nominating her for Imperial's Emerging Leader Alumni Award, a team of Ibolya's colleagues cited her “rare capacity to anticipate academic and industry needs and to respond with forward-thinking, practical solutions.” At the NPL, as a Senior Scientist, she works with a team of researchers in collaboration at both a national and international level. How has her approach to leadership evolved with her career?
“I began as a very solution-driven scientist, focused on solving the immediate technical challenge,” she says.
Over time, I have learned that real progress in science comes not only from finding solutions myself, but from creating an environment where a team can generate ideas, take ownership and grow in confidence. Empowering people has become central to my leadership style.
“Modern science is a complex ecosystem: physics, biology, engineering, data science and clinical expertise must all come together. Innovation and creativity emerge precisely at these intersections. My role as a leader is to connect those perspectives, to create the conditions where excellent ideas can surface, and to support the individuals who bring them forward.”
International standardisation committee meeting in Incheon, Republic of Korea (2025)
International standardisation committee meeting in Incheon, Republic of Korea (2025)
As a leader, she believes strongly in equity and inclusion.
“We need diverse minds scientifically, culturally and socially to tackle the most difficult questions. If we limit participation to certain backgrounds or major economies, we miss out on perspectives that could fundamentally reshape our understanding and accelerate discovery. A more equitable scientific community is not only fairer; it is more innovative.
“So my leadership philosophy today is about people, not just problems: building teams that feel valued and empowered, nurturing creativity across disciplines, and ensuring that the scientific landscape remains open to talent wherever it comes from. That is how we achieve the most meaningful breakthroughs.”
Supporting the next generation
Ibolya supports the Imperial College London Hardship Fund, reflecting her belief that financial difficulties should not be a barrier to academic success. Her personal contributions help students in crisis continue their studies, underscoring her commitment to fairness and the transformative power of education. She also remains engaged with the university’s community, hosting scientific visits of Imperial delegations at NPL. What advice does she give to the next generation of scientists?
My advice is to take full advantage of the environment you’re in. Imperial gives you extraordinary access to expertise, facilities and people — don’t hesitate to explore beyond your immediate field. Some of the most meaningful insights come from conversations with researchers who think differently from you.
She also urges young scientists to embrace challenges rather than avoid them. “The moments that feel uncertain or uncomfortable are often the ones that shape your scientific maturity. In my own PhD, the biggest breakthroughs came from situations where I had to rethink everything.”
Lastly, she says, “stay connected to the real-world impact of your work. Whether your interest is diagnostics, engineering, biology or something else entirely, remember that the science you are doing has the potential to transform lives. Keeping that perspective can be deeply motivating, especially on the difficult days.”
Words by Sarah Webb | Photography by Jason Alden | Editing and design by Ellie Cawthera
Imperial's Alumni Awards recognise the outstanding achievements of our alumni community and the variety of ways they are making a real impact across the globe.
The Emerging Alumni Leader Award recognises and celebrates our rising stars, innovators, game-changers and future leaders.
